In this multicentre , randomised , double-masked , placebo-controlled trial , we enrolled corticosteroid unresponsive adult patients ( aged @ years ) with primary immune thrombocytopenia and a platelet count of less than @ ( @ ) platelets per L. Patients were randomly assigned ( @:@ ) to four weekly infusions of @ mg/m ( @ ) rituximab or placebo .